Pear Therapeutics, Inc.
DelistedCIK 1835567fmd_00J9PPFZD4E848F7WQ8WXDY1XFServices · Services-Health ServicesTemplate: Standard
Coverage: Jan 01, 2020 to Dec 31, 2022, 9 periods
| Line item | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Total revenues | 9 | 4 | 13 |
| Cost of revenue | 2 | 5 | 8 |
| Net interest income | (2) | (4) | (4) |
| Gross profit | 8 | (1) | 5 |
| Research and development | 28 | 37 | 48 |
| Selling, general and administrative | 56 | 68 | 80 |
| Operating income | (77) | (106) | (123) |
| Other non-operating income (expense) | (20) | 41 | 48 |
| Income tax expense | 0 | 0 | 0 |
| Net income | (97) | (65) | (75) |
| Net income to common shareholders | (108) | (65) | (75) |